BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
BACKGROUND: The Model for End-Stage Liver Disease-Sodium (MELDNa) is an established metric of 3-month waitlist mortality (WLM) in cirrhosis patients but underestimates mortality risk in certain subgroups…
Management of advanced hepatocellular carcinoma (HCC) has been transformed by immune checkpoint inhibitors (ICIs), which are now first-line systemic therapies…